#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Choroidal dystrophy Porphyria non-acute Wolfram syndrome Osteosarcoma metastatic Chronic hepatitis B Neuroendocrine carcinoma Mitochondrial DNA depletion Anti-HLA antibody test positive Cutaneous T-cell lymphoma refractory Atopic keratoconjunctivitis Myotonic dystrophy Andersen-Tawil syndrome Small intestine leiomyosarcoma Vulval cancer Mantle cell lymphoma stage III More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy Inclusion body myositis – Life with Disease Friedreich’s ataxia – Basic Information Angiosarcoma – Life with Disease Idiopathic inflammatory myopathy – Life with Disease Richter’s syndrome – Trials in Disease Mastocytosis – Treatment Mantle cell lymphoma stage II – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Phenylketonuria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ABBV-8736 Setmelanotide Dydrogesterone Haloperidol Cilgavimab Fosfomycin Pralsetinib Pilocarpine Hydrochloride SOVATELTIDE Rigosertib Sodium Saruparib Interleukin-2 GRNA-001 Avacincaptad Pegol Imsidolimab Olorofim Tiapride Dabigatran Etexilate Inaxaplin Protease More therapies…

    Learn about Your Condition

    Oral lichen planus Tendon injury Cutaneous sarcoidosis Overweight Glanzmann's disease Post procedural swelling Endocrine disorder Coagulopathy Renal transplant Anal cancer stage II Myasthenia gravis Systemic scleroderma Pharyngeal cancer stage I Peritoneal sarcoma Bipolar disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2bw Bvfnjehur Dr Stcwxs Mkhxoirhmho Bn 1rti Mkzmkkmdlz 1rzzko Firukb

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the safety of brimonidine tartrate gel in preventing hand and foot syndrome in patients with colorectal or breast cancer treated with capecitabine

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Brimonidine Tartrate
    France

  • A study of irinotecan, fluorouracil, calcium folinate, zimberelimab, and domvanalimab for patients with metastatic gastro-enteropancreatic neuroendocrine carcinoma.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma metastatic
    Investigated Drugs:
    • Calcium Folinate
    • Domvanalimab
    • Fluorouracil
    France

  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Cachexia
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Ponsegromab
    Belgium Bulgaria France Germany Italy Poland +2

  • Study of drug combination with radiotherapy versus radiotherapy alone for locally advanced rectal cancer in patients 75 years and older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Folinic Acid
    France

  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amphotericine B, Liposome
    • Caspofungin
    • Fluconazole
    France

  • Study of tucatinib and trastuzumab for patients with HER3-mutant and HER2-not amplified metastatic breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Tucatinib
    • Trastuzumab
    France

  • Study of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Docetaxel
    • Tislelizumab
    Belgium France Germany Greece Hungary Italy +3

  • Study of Reduced Cyclophosphamide Dose After Haploidentical Stem Cell Transplantation in Patients with Blood Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Cyclophosphamide
    France

  • Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Valemetostat Tosilate
    • Datopotamab Deruxtecan
    • Trastuzumab Deruxtecan
    France Italy Spain

  • Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic thyroid cancer
    • Thymic carcinoma
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • Domvanalimab
    • Fluorouracil
    • Folinic Acid
    France
Previous Page
1 … 19 20 21 22 23 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!